TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain

TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain

Overview

This synthesis documents the causal chain from TBK1 loss-of-function mutations to selective autophagy impairment to neuroinflammation and ALS/FTD. The TBK1 causal chain connects two critical cellular pathways — selective autophagy and innate immunity — and represents a significant therapeutic target.

This chain is part of our broader [Gene-Mechanism-Therapy Causal Chains](/mechanisms/gene-mechanism-therapy-causal-chains) synthesis and complements our [TBK1 Gene](/genes/tbk1), [OPTN](/genes/optn), and [SQSTM1/p62](/genes/sqstm1) pages.

The Causal Chain

```mermaid
flowchart TD
subgraph Genetic["Genetic Lesion"]
A["TBK1 LOF Mutations<br/>Missense/Nonsense/Frameshift"] --> B["Haploinsufficiency<br/>Reduced TBK1 Activity"]
end

subgraph Autophagy["Autophagy Dysfunction"]
B --> C["Impaired OPTN<br/>Phosphorylation"]
B --> D["Impaired p62/SQSTM1<br/>Phosphorylation"]
C --> E["Reduced Ubiquitin<br/>Chain Binding"]
D --> F["Reduced Cargo<br/>Recognition"]
E --> G["Defective Selective<br/>Autophagy"]
F --> G
G --> H["Mitochondrial<br/>Accumulation"]
G --> I["Protein Aggregate<br/>Accumulation"]
end

subgraph Inflammation["Neuroinflammation"]
G --> J["Cellular Debris<br/>Accumulation"]
J --> K["Microglial<br/>Activation"]
K --> L["Chronic<br/>Neuroinflammation"]
end

TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain

Overview

This synthesis documents the causal chain from TBK1 loss-of-function mutations to selective autophagy impairment to neuroinflammation and ALS/FTD. The TBK1 causal chain connects two critical cellular pathways — selective autophagy and innate immunity — and represents a significant therapeutic target.

This chain is part of our broader [Gene-Mechanism-Therapy Causal Chains](/mechanisms/gene-mechanism-therapy-causal-chains) synthesis and complements our [TBK1 Gene](/genes/tbk1), [OPTN](/genes/optn), and [SQSTM1/p62](/genes/sqstm1) pages.

The Causal Chain

Chain Element Breakdown

1. Genetic Risk: TBK1 Loss-of-Function Mutations

| Element | Details |
|---------|---------|
| Gene | [TBK1](/genes/tbk1) - TANK-binding kinase 1 |
| Chromosome | 12q14.2 |
| Inheritance | Autosomal dominant (haploinsufficiency) |
| Prevalence | ~3-5% familial ALS, ~3-5% familial FTD |
| Key Variants | E696K, I397T, R357X, various LOF mutations |
| Mechanism | Loss-of-function → haploinsufficiency |

Genetic Evidence:

• Cirulli et al. (2015) identified TBK1 as a major ALS risk gene through exome sequencing[@cirulli2015]
• Freischmidt et al. (2015) demonstrated TBK1 haploinsufficiency causes familial ALS-FTD[@freischmidt2015]
• Gijselinck et al. (2015) confirmed TBK1 as third most common cause of familial FTD[@gijselinck2015]

2. Molecular Dysfunction: Autophagy Receptor Dysregulation

TBK1 phosphorylates critical autophagy receptors:

| Receptor | TBK1 Phosphorylation Site | Functional Effect |
|----------|---------------------------|-------------------|
| [OPTN](/proteins/optineurin-protein) | Ser473 | Enhanced ubiquitin chain binding |
| [SQSTM1/p62](/proteins/sqstm1-p62-protein) | Ser403 | Increased cargo recognition |
| NDP52 (CALCOCO2) | Multiple | Mitochondrial recruitment |

Mechanism: TBK1 loss impairs phosphorylation of these receptors, reducing their ability to bind ubiquitinated cargo and recruit autophagosomes. This creates a bottleneck in selective autophagy[@matsumoto2015][@richter2016].

3. Pathway Consequences

Mitophagy Failure

• Damaged mitochondria not eliminated
• Accumulation of dysfunctional mitochondria
• Increased ROS production
• ATP depletion

Protein Aggregate Clearance Failure

• Impaired clearance of ubiquitinated proteins
• Accumulation of protein aggregates
• TDP-43 pathology in affected neurons

4. Neuroinflammation

TBK1 deficiency in microglia induces:

• Aged-like microglial transcriptional signature[@bhargava2025]
• Impaired phagocytic capacity
• Altered cytokine production
• Chronic neuroinflammation

5. Disease Phenotype

| Disease | Key Features |
|---------|---------------|
| ALS | Motor neuron loss, progressive paralysis |
| FTD | Behavioral variant, language deficits |
| ALS/FTD | Overlapping syndrome |

Therapeutic Implications

Autophagy Enhancement

| Approach | Status | Agent |
|----------|--------|-------|
| mTOR inhibition | Preclinical | Rapamycin |
| TFEB activation | Preclinical | Trehalose, TFEB agonists |
| USP30 inhibition | Preclinical | Enhance mitophagy |

Gene Therapy

| Approach | Status | Agent |
|----------|--------|-------|
| AAV-TBK1 | Preclinical | Restore TBK1 expression |
| OPTN modulators | Preclinical | Bypass TBK1 |

Small Molecules

| Target | Status | Agent |
|--------|--------|-------|
| Autophagy inducers | Preclinical | Rapamycin, trehalose |
| Neuroinflammation | Research | C3aR antagonists |

Clinical Development Landscape

| Therapy | Target | Stage | Company |
|---------|--------|-------|---------|
| Autophagy inducers | mTOR/TFEB | Preclinical | Various |
| Gene therapy | TBK1 | Preclinical | Research |

Relationship to Other Mechanisms

Intersection with PINK1/Parkin Pathway

TBK1 acts downstream of PINK1/Parkin in mitophagy:

• PINK1 senses mitochondrial damage
• Parkin ubiquitinates mitochondria
• TBK1 phosphorylates OPTN/p62 to complete engulfment

cGAS-STING Connection

TBK1 normally regulates cGAS-STING-mediated interferon responses:

• TBK1 loss dysregulates this pathway
• Chronic activation contributes to neuroinflammation

Cross-Links

• [TBK1 Gene](/genes/tbk1)
• [OPTN](/genes/optn)
• [SQSTM1/p62](/genes/sqstm1)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [FTD](/diseases/frontotemporal-dementia)
• [Selective Autophagy](/mechanisms/autophagy-lysosome-dysfunction)
• [PINK1/Parkin Pathway](/mechanisms/pink1-parkin-mitophagy-pd-causal-chain)
• [cGAS-STING Pathway](/mechanisms/cgas-sting-neurodegeneration)

References